Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioCorRx (BICX) EBT Margin (2016 - 2025)

BioCorRx (BICX) has disclosed EBT Margin for 15 consecutive years, with 125.35% as the latest value for Q4 2025.

  • Quarterly EBT Margin changed N/A to 125.35% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 204.12% through Dec 2025, up 6779461.0% year-over-year, with the annual reading at 440.11% for FY2025, 6755861.0% up from the prior year.
  • EBT Margin hit 125.35% in Q4 2025 for BioCorRx, down from 0.45% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 0.45% in Q3 2025 to a low of 34184.06% in Q1 2024.
  • Historically, EBT Margin has averaged 8278.74% across 5 years, with a median of 4910.16% in 2023.
  • Biggest five-year swings in EBT Margin: crashed -3168752bps in 2024 and later skyrocketed 3355265bps in 2025.
  • Year by year, EBT Margin stood at 8839.34% in 2021, then skyrocketed by 84bps to 1394.3% in 2022, then crashed by -267bps to 5116.74% in 2023, then plummeted by -496bps to 30506.7% in 2024, then soared by 100bps to 125.35% in 2025.
  • Business Quant data shows EBT Margin for BICX at 125.35% in Q4 2025, 0.45% in Q3 2025, and 772.72% in Q2 2025.